HORIZON update: Using melflufen to treat RRMM patients refractory to daratumumab and/or pomalidomide
HORIZON update: Using melflufen to treat RRMM patients refractory to daratumumab and/or pomalidomide
The changing landscape of AML
Cancer care in low and middle income countries
Cancer care in Latin America
Surveying cancer patients' mental health and financial problems
Implementing better cancer diagnosis in low and middle income countries
Project Pink Blue: Fighting cancer through increasing awareness, screening, advocacy and patient navigation
Challenges in global cancer control
Novel methods of drug testing and biopsy in India
Cutting-edge cancer care at the Miami Cancer Institute
Use of maintenance therapy following ASCT and real world treatment patterns in multiple myeloma
Comment: Fixed-duration venetoclax plus obinutuzumab in patients with CLL and comorbidities